Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Aug 16, 2024

SELL
$6.71 - $12.55 $838 - $1,568
-125 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$4.56 - $7.88 $570 - $985
125 New
125 $841,000
Q1 2021

Aug 16, 2024

BUY
$3.02 - $4.51 $377 - $563
125 New
125 $443,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.